Mangoceuticals acquires a global patent portfolio [Seeking Alpha]
Mangoceuticals, Inc. (MGRX)
Company Research
Source: Seeking Alpha
"We believe that the acquired technology represents a breakthrough in preventive care. The acquired technology is protected by a global patent portfolio including U.S. and international patent rights," said the company. Under the agreement the company has agreed to pay Intramont a total of $20M for the patent portfolio, through the issuance of 980K shares of its newly created 6% series C convertible preferred shares/ Recommended For You More Trending News MGRX - Mangoceuticals, Inc. Recommended For You More Trending News About MGRX Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
MGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGRX alerts
High impacting Mangoceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MGRX
News
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement [Yahoo! Finance]Yahoo! Finance
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity RequirementGlobeNewswire
- Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareGlobeNewswire
- Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsGlobeNewswire
- MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®? FDA Approved Oral Testosterone Replacement Therapy (TRT) TreatmentGlobeNewswire
MGRX
Sec Filings
- 5/14/24 - Form S-8
- 5/10/24 - Form EFFECT
- 5/6/24 - Form S-1/A
- MGRX's page on the SEC website